Intensive Short-Term Dynamic Psychotherapy (ISTDP) for Anxiety Diagnoses in a Primary Care Setting
Anxiety Treatment in Primary Care: an Evaluation of Intensive Dynamic Short-term Therapy
1 other identifier
interventional
30
1 country
1
Brief Summary
Living with anxiety often means great suffering for the person affected. The trend points to a continued increase in anxiety problems in the population, especially in the 18-44 age group. Inadequate treatment of this condition can lead to long-term sick leave, isolation, exclusion and, in the worst case, to death. The treatment methods that are available in primary care today help some but far from all. Therefore, the investigators want to scientifically evaluate a shorter version of a proven emotion-focused psychotherapy in order to increase the treatment range for this patient group. The aim of this project is to, in a primary care setting, test and evaluate an intensive, emotion-focused short-term therapy, ISTDP (Intensive Short-Term Dynamic Psychotherapy) for patients with an anxiety diagnosis. The method is well-proven on patients with more severe mental conditions (personality disorders) with good results, but the treatment has only been tested to a limited extent on patients with anxiety symptoms. The investigators want to investigate the effectiveness of treating various anxiety states for primary care patients. The treatment is expected to provide an addition to today's methods, which overall will provide better treatment results for this, increasing in number, group of patients who often seek primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2023
CompletedFirst Posted
Study publicly available on registry
May 18, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 31, 2023
May 1, 2023
1.9 years
April 27, 2023
May 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Generalized Anxiety Disorder-7 (GAD-7) scorings
Self-report measure. The GAD-7 consists of 7 items which are scored 0-3, with a total score ranging from 0-21. Higher scores correspond to worse outcome. measures
Changes in scorings from baseline scorings to scorings after 9-10 months.
Secondary Outcomes (3)
The Perceived Health Questionnaire (PHQ-9) scorings
Changes in scorings from baseline scorings to scorings after 9-10 months.
The Panic Disorder Severity Scale (PDSS) scorings
Changes in scorings from baseline scorings to scorings after 9-10 months.
The Brunnsvikens Brief Quality of Life Inventory (BBQ) scorings
Changes in scorings from baseline scorings to scorings after 9-10 months.
Study Arms (1)
Treated
EXPERIMENTALParticipants are their own controls when they are on the waiting list before treatment, and they will later be treated with the ISTDP.
Interventions
A dynamic and intensive psychotherapy with eight therapeutic sessions
Eligibility Criteria
You may qualify if:
- Primary Care patients with primary anxiety diagnoses at a Health Care clinic in Sweden. Sufficient language competence in Swedish is required of the participants to understand, read, speak and write.
You may not qualify if:
- Major reading-writing and learning difficulties, severe psychiatric problems such as psychosis, eating disorder, current major depression, recurrent depression, severe trauma, acute crisis reaction, exhaustion, acute risk of suicide (assessed according to the suicide scale), addiction.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Linnaeus Universitylead
- Kalmar County Hospitalcollaborator
Study Sites (1)
Region Kalmar
Kalmar, 391 85, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Cecilia Fagerström, Professor
Director of the Research Board in Region Kalmar
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
April 27, 2023
First Posted
May 18, 2023
Study Start
September 1, 2023
Primary Completion
August 1, 2025
Study Completion
December 1, 2025
Last Updated
May 31, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share